The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...

A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

Prostate cancer is the second most common cancer diagnosis in men. 1 in 8 men will be diagnosed with the disease during their ...

After managing two bouts of ovarian cancer, CNN's Christiane Amanpour reveals that she has it for a third time. 'I decided to ...

MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has dosed the first patient in a Phase 1 ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...

In hormone-sensitive prostate cancer, an alternative dosing of docetaxel plus Nubeqa and ADT was associated with improvements in side effect rates.

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...